Literature DB >> 31967297

Allotype-specific processing of the CD16a N45-glycan from primary human natural killer cells and monocytes.

Kashyap R Patel1, Jacob T Roberts1, Adam W Barb2,3.   

Abstract

Fc γ receptor IIIa/CD16a is an activating cell surface receptor with a well-defined role in natural killer (NK) cell and monocyte effector function. The extracellular domain is decorated with five asparagine (N)-linked glycans; N-glycans at N162 and N45 directly contribute to high-affinity antibody binding and protein stability. N-glycan structures at N162 showed significant donor-dependent variation in a recent study of CD16a isolated from primary human NK cells, but structures at N45 were relatively homogeneous. In this study, we identified variations in N45 glycan structures associated with a polymorphism coding for histidine instead of leucine at position 48 of CD16a from two heterozygous donors. It is known that H48 homozygous individuals suffer from immunodeficiency and recurrent viral infections. A mass spectrometry analysis of protein isolated from the primary natural killer cells of individuals expressing both CD16a L48 and H48 variants demonstrated clear processing differences at N45. CD16a H48 displayed a greater proportion of complex-type N45 glycans compared to the more common L48 allotype with predominantly hybrid N45-glycoforms. Structures at the four other N-glycosylation sites showed minimal differences from data collected on donors expressing only the predominant L48 variant. CD16a H48 purified from a pool of monocytes similarly displayed increased processing at N45. Here, we provide evidence that CD16a processing is affected by the H48 residue in primary NK cells and monocytes from healthy human donors.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Fc gamma receptor; N-glycan; glycoproteomics; immunodeficiency 20

Year:  2020        PMID: 31967297      PMCID: PMC7305797          DOI: 10.1093/glycob/cwaa002

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  31 in total

1.  CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 2.  Functions of natural killer cells.

Authors:  Eric Vivier; Elena Tomasello; Myriam Baratin; Thierry Walzer; Sophie Ugolini
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

3.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

Authors:  L L Lanier; A M Le; C I Civin; M R Loken; J H Phillips
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

Review 4.  Immunoglobulin G glycosylation in aging and diseases.

Authors:  Ivan Gudelj; Gordan Lauc; Marija Pezer
Journal:  Cell Immunol       Date:  2018-07-23       Impact factor: 4.868

5.  Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.

Authors:  Kashyap R Patel; Jacob T Roberts; Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

6.  Site-specific N-glycan Analysis of Antibody-binding Fc γ Receptors from Primary Human Monocytes.

Authors:  Jacob T Roberts; Kashyap R Patel; Adam W Barb
Journal:  Mol Cell Proteomics       Date:  2019-12-30       Impact factor: 5.911

Review 7.  Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Front Immunol       Date:  2016-12-02       Impact factor: 7.561

8.  Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer.

Authors:  Yu Fan; Yu Hu; Cheng Yan; Radoslav Goldman; Yang Pan; Raja Mazumder; Hayley M Dingerdissen
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

9.  Glycoproteogenomics: A Frequent Gene Polymorphism Affects the Glycosylation Pattern of the Human Serum Fetuin/α-2-HS-Glycoprotein.

Authors:  Yu-Hsien Lin; Jing Zhu; Sander Meijer; Vojtech Franc; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2019-05-16       Impact factor: 5.911

10.  Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.

Authors:  Lisa L Liu; Johannes Landskron; Eivind H Ask; Monika Enqvist; Ebba Sohlberg; James A Traherne; Quirin Hammer; Jodie P Goodridge; Stella Larsson; Jyothi Jayaraman; Vincent Y S Oei; Marie Schaffer; Kjetil Taskén; Hans-Gustaf Ljunggren; Chiara Romagnani; John Trowsdale; Karl-Johan Malmberg; Vivien Béziat
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

View more
  8 in total

Review 1.  From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement.

Authors:  Loïs Coënon; Martin Villalba
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

2.  The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites.

Authors:  Elizabeth A Lampros; Paul G Kremer; Jesús S Aguilar Díaz de León; Elijah T Roberts; Maria Carolina Rodriguez Benavente; I Jonathan Amster; Adam W Barb
Journal:  Curr Res Immunol       Date:  2022-06-09

3.  Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.

Authors:  Lilin Li; Zijian Huang; Kunpeng Du; Xiang Liu; Chunhui Li; Duanyu Wang; Yangfeng Zhang; Changqian Wang; Jiqiang Li
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

4.  Method for Identifying Galectin Ligands on Lymphocyte Membrane Glycoproteins.

Authors:  Kashyap R Patel; Adam W Barb; Sean R Stowell
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Heterogeneity in IgG-CD16 signaling in infectious disease outcomes.

Authors:  Joseph C Gonzalez; Saborni Chakraborty; Natalie K Thulin; Taia T Wang
Journal:  Immunol Rev       Date:  2022-07-03       Impact factor: 10.983

6.  Role of N-Glycosylation in FcγRIIIa interaction with IgG.

Authors:  Julie Van Coillie; Morten A Schulz; Arthur E H Bentlage; Noortje de Haan; Zilu Ye; Dionne M Geerdes; Wim J E van Esch; Lise Hafkenscheid; Rebecca L Miller; Yoshiki Narimatsu; Sergey Y Vakhrushev; Zhang Yang; Gestur Vidarsson; Henrik Clausen
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

Review 7.  Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development.

Authors:  Adam W Barb
Journal:  J Biol Chem       Date:  2020-11-22       Impact factor: 5.157

8.  Peak Filtering, Peak Annotation, and Wildcard Search for Glycoproteomics.

Authors:  Abhishek Roushan; Gary M Wilson; Doron Kletter; K Ilker Sen; Wilfred Tang; Yong J Kil; Eric Carlson; Marshall Bern
Journal:  Mol Cell Proteomics       Date:  2020-12-08       Impact factor: 5.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.